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In this issue of Immunity, Obermoser et al. (2013) systematically analyze and compare the blood-transcrip-
tomic response of the pneumococcal and influenza vaccines in humans over multiple time points spanning
hours to tens of days. They then present web-based interactive figures that facilitate exploration of this large,
complex data set.Advances in high-throughput multiplexed
technologies for measuring states of bio-
logical systems from molecules, to cells,
to whole organisms are rapidly turning
biology into a ‘‘big data’’ science. Immu-
nology is no exception. Although the
immune system and its response to
perturbations such as infection and can-
cer are invariably complex, involving intri-
cate molecular and cellular orchestrations
over space and time, the increasingly
comprehensive view offered by global
studies of immunity complements more
traditional approaches to chip away at
this complexity. Microarray profiling of
peripheral blood before and after yellow
fever and influenza vaccination, for
instance, has revealed both expected
(e.g., plasmablast) and new response
signatures and has led to novel hypothe-
ses on the genetic regulation of anti-
body and CD8+ T cell responses, which
in turn could help facilitate rational
design of new vaccines (Pulendran et al.,
2010). The extent to which immune
responses vary among different vaccines,
however, remains largely unexplored at
the genome-wide scale. In this issue of
Immunity, Obermoser et al. (2013) sys-
tematically and comprehensively com-
pare the blood-transcriptomic responses
of twowidely used vaccines: the pneumo-
coccal vaccine, composed of polysac-
charide extracts, and the influenza split
vaccine, which comprises inactivated
viral components.
In addition to providing a comprehen-
sive analysis of the shared and distinct
transcriptome signatures induced by two
important vaccines, this work contributes
a rich data set for the investigation of
vaccine responses in humans. However,
exploration of such large data sets re-622 Immunity 38, April 18, 2013 ª2013 Elsevquires custom bioinformatics analysis,
which is typically accessible only to indi-
viduals with computational and statistical
expertise. Here, the authors provide an
innovative solution: for the first time in
Immunity (and to the best of our knowl-
edge, in any scientific journal), readers
can further explore the data (not just the
images) presented in all of the figures
through an aesthetically appealing and
functionally rich set of web tools called
interactive figures (iFigures). These inter-
active data-browsing and analysis tools
render such complex data sets immedi-
ately accessible to a diverse biological
audience.
The design of this study is noteworthy
(Figure 1). In addition to the typical time
points (days 0, 1, 3, and 7) profiled in
previous studies of yellow fever and influ-
enza vaccination, this work investigates
longer-term responses by sampling from
days 10, 14, 21, and 28. To examine
innate responses over a dense set of early
time points in the scale of hours after
vaccination, the authors profile minute
amounts of blood from finger-prick sam-
ples in a separate cohort of individuals.
Also included is a parallel placebo arm
with the same set of time points wherein
saline was administered in lieu of the
vaccine. The lack of substantial response
activity following saline injection provides
reassurance that the data-generation
platforms are robust; it also indicates
that intramuscular injection elicits minimal
transcriptomic activities in the blood;
thus, those observed in the main arms
are vaccine specific. Another nice feature
is the inclusion of an extra prevaccination
time point (day 7) for obtaining more
robust baseline estimates. The cohort
sizes are relatively small, making robustier Inc.inference of correlates of immunogenicity
and control for confounding by outlier in-
dividuals difficult. However, the sample
size is sufficient for deriving robust vac-
cine signatures, and the careful design
and methodology of the study will serve
as an invaluable reference for future
blood-transcriptomic studies in humans,
such as ones involving pediatric subjects,
dense time points, and minute blood
volumes.
Amajor challenge in any study involving
large-scale data is the transformation of
such data sets into biological insights,
and one of the main obstacles is the curse
of the high dimensionality of such data
sets. The authors address this in a couple
of ways. First, they reduce the dimension-
ality of transcriptomic responses from
tens of thousands of genes to 62 function-
ally annotated gene modules, which are
sets of coexpressed genes derived from
multiple independent blood-transcrip-
tomic data sets (Chaussabel et al.,
2008). Similarly, they draw insights from
a host of early responding genes by
comparing them to a manageable set of
innate transcriptomic signatures, which
are obtained from the stimulation of
in vitro blood cell culture with diverse
stimuli, including cytokines, Toll-like re-
ceptor (TLR) ligands, live viruses, and
killed bacteria. Second, iFigures provide
a point-and-click web interface to
expand the static views of traditional
figures and allow the reader to explore
the data from different perspectives,
thus offering a great level of flexibility
and transparency. The reader can now
test the robustness of the authors’ con-
clusions to different p value or fold-
change cutoffs, inspect the flow-cytome-
try gating details when examining figures
Figure 1. Study Design and an Example of Using the Interactive Figures to Explore the Data
The top section depicts the study design: threeparallel arms for saline, influenza, or pneumococcal vaccine
injections. These armswere performed twice in different cohorts: once for profiling samples from early time
points in the scale of hours and the other for time points in the scale of days following injection. This study
generates large-scale data that canbe explored furtherwith interactive figures (Obermoser et al., 2013) that
accelerate finding answers to specific questions. Here, we illustrate the use of the interactive figures by
inspecting the specificity of expression patterns of a gene in a cytotoxic activity module that was
mentioned, but not elaborated on, in the paper. Source of the ‘‘data’’ image: luckey_sun at Flickr.com.
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and select and further investigate the
genes inside modules of interest (Fig-
ure 1)—these are but a few of the
myriad exploratory possibilities. Although
releasing the raw data, as the authors are
also doing with this work, is crucial for
enabling unrestricted exploratory anal-
ysis, model building, integration with
data from other studies, and further hy-
pothesis generation, iFigures extend the
reach of many of these exercises from
computational experts to biologists with
limited bioinformatics expertise.
The comparative exercise undertaken
in the paper revealed that within hours
both vaccines can induce meaningful
transcriptomic responses in the blood,
with interferon and inflammatory/TLR-
inducible genes predominant for the
influenza and pneumococcal vaccines,
respectively. For both vaccines plasma-
blast responses were apparent by day 7,
but the pneumococcal vaccine had a
more sustained response that lasted until
day 10, as seen in both microarray and
flow-cytometry data. These interesting
observations raise further questions:
e.g., how do differences in early re-
sponses affect the duration and level of
the plasmablast response? Answers to
this question can point to strategies for
designing more potent vaccines. The cur-rent data also leave open the question of
themechanisms that drive themarked dif-
ferences between the vaccines. Expres-
sion profiling of sorted cell subsets from
the influenza vaccinees indicated that the
interferon signature originated from neu-
trophils and monocytes, but which cell
subset produced the interferon is less
clear. A related question is where neutro-
phil stimulation took place—at the site of
injection or further downstream? To begin
to answer these questions, future studies
could consider simultaneous profiling of
blood and tissue biopsies from the injec-
tion site; utilizing mouse models from
which tissue samples can be obtained
more readily could also prove valuable.
In general, correlating responses in tis-
sues to those in blood would be highly
informative and could start to reveal
molecular and cellular mechanisms that
give rise to blood response signatures.
Data from this and other large-scale
studies of human immunity together with
ongoing efforts (e.g., those from the
Human Immunology Project Consortium
and the National Institutes of Health’s
Center for Human Immunology, Autoim-
munity, and Inflammation [Leslie, 2010])
will begin to provide increasingly compre-
hensive characterizations of the human
immune system, e.g., before and after
vaccine and drug intervention in healthyImmunityand disease-affected individuals. Proper
integration of these dense data sets will
start to provide a human ‘‘immune state’’
atlas—akin to the Connectivity Map for
functional genomics and drug discovery
(Lamb et al., 2006)—useful for probing
and comparison of immune statuses
under diverse settings and for reverse en-
gineering functional interactions among
immune-system components based on
correlations among the observed pheno-
types across individuals (Marbach et al.,
2012). In addition to proper design (e.g.,
sufficiently large cohort sizes) and execu-
tion at the individual study level, achieving
this goal requires overcoming several ob-
stacles, such as the standardization of
experimental practices and technology
platforms, the identification of confound-
ing covariates, and the development of
approaches for normalization across
studies, as well as agreeing to common
data-dissemination and replication stan-
dards. Some of these, such as data-pro-
cessing standards and sharing policies,
can be partially borrowed from similar
efforts in related fields (e.g., The Cancer
Genome Atlas [Chin et al., 2011]); others
need further research innovation as well
as collaboration and dialog across the
research community. The biggest chal-
lenge and opportunity, however, lies in
the development of novel concepts and
approaches to turn such data compendia
into immunological insights and predic-
tive constructs for unseen perturbations.
For example, predictive models have
been built for disease prognosis (van ’t
Veer et al., 2002) and are being explored
at levels ranging from molecular interac-
tions to whole cells (Bonneau et al.,
2007; Karr et al., 2012). Extending these
by incorporating key elements of immu-
nity (e.g., cell-cell interactions; spatial
and temporal considerations) and proper
abstraction and modeling across different
biological scales will help usher in an era
of immunology in which the systematic
collection of large-scale data sets such
as the one presented in this study is
combined with computational andmathe-
matical modeling to systematically chip
away at the complexity of the human
immune system in health and disease.REFERENCES
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Two studies in the current issue of Immunity (Pratama et al., 2013; Vogel et al., 2013) demonstrate that the
RNA-binding proteins Roquin-1 and Roquin-2 have redundant function in the posttranscriptional repression
of Icos messenger RNA by CD4+ T cells.CD4+ follicular helper T (Tfh) cells promote
maturation of B cells into memory or anti-
body-secreting plasma cells in germinal
centers (GCs) of secondary lymphoid
organs (SLOs) (Craft, 2012). Similarly,
autoantibodies in diseases such as sys-
temic lupus erythematosus (SLE, or lupus)
are produced via GC B cells, with
dysfunctional Tfh cells necessary for their
development (Vinuesa et al., 2009). Two
papers in this issue of Immunity provide
new insights into the regulation of Tfh
cell help for GC B cells and how this reg-
ulatory pathway might be subverted in
autoimmune conditions such as lupus
(Pratama et al., 2013; Vogel et al., 2013).
For naive CD4+ T cells fated to the Tfh
developmental pathway, antigen priming
by dendritic cells (DCs) in T cell zones of
SLOs results in upregulation of the induc-
ible costimulator (ICOS). ICOS signaling,
delivered by ICOS ligand (ICOS-L) ex-
pressed on T-zone DCs, is required for
development and expansion of Tfh cells
and expression of their canonical tran-
scription factor Bcl6 (Choi et al., 2011).ICOS, a member of the CD28-superfamily
of costimulatory molecules, is upregu-
lated by T cells upon activation, unlike
its constitutively expressed sister mole-
cule CD28 (Linterman et al., 2009). The
Icos gene originated through duplication
of the Cd28 locus, making the differential
expression of their protein products a
curiosity. CD28 provides the crucial sec-
ond step in T cell activation upon binding
its cognate ligands CD80 and CD86,
upregulated on DCs following recognition
of microbial products. Unlike CD28
ligands, however, ICOS-L is constitutively
present on DCs; consequentially, induc-
ible ICOS expression imparts regulation
of T cell activation and subsequent Tfh
cell induction. The RNA-binding protein
Roquin-1, a RING (really interesting new
gene)-domain containing product of the
Rc3h1 gene, posttranscriptionally regu-
lates Icosmessenger RNA (mRNA), main-
taining activation-induced expression of
ICOS in CD4+ T cells (Vinuesa et al.,
2005) (Figure 1). Recognition of the 30
untranslated region of this mRNA by theRNA-binding domain of Roquin-1 facili-
tates degradation of the transcript
through interactions with the decapping
enzyme Edc4 and helicase Rck (Glas-
macher et al., 2010). Roquin expression
is repressed upon activation of CD4+
T cells via degradation of the Rc3h1 tran-
script by the miR-223 microRNA (miRNA),
allowing for the regulated expression of
target transcripts.
Previous studies by Vinuesa and col-
leagues identified a role for the Roquin
protein in mRNA regulation by using
mice with a single-base substitution in
the Rc3h1 locus, leading to alterations in
Roquin structure and activity (Vinuesa
et al., 2005). Animals with homozygosity
of themutant allele,Rc3h1san/san or sanro-
que, had ICOS overexpression on CD4+
T cells, a consequence of the mutant
Roquin protein, with Bcl6 upregulation
and Tfh cell expansion upon immuniza-
tion, leading to robust GCs and plasma
cells producing isotype-switched anti-
bodies and a lupus-like phenotype (Fig-
ure 1). Roquin-1 localized to cytosolic
